These results suggest that targeted inhibition of the ZMIZ1-Notch1 signaling pathway may reduce the expression of invasion and metastasis-related factors (MKP-1, SSBP2, and MMP7), thereby suppressing the invasion and metastasis potential of TSCC tumor cells. The gene discussed is SSBP2; the disease is neoplasm.